Skip to content

Colposcopy Anxiety and the Role of Pre-procedure Nursing Intervention

Anxiety Related to Colposcopy and the Impact of Pre-colposcopy Intervention by a Clinical Nurse

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07092189
Enrollment
140
Registered
2025-07-29
Start date
2024-01-08
Completion date
2025-07-14
Last updated
2025-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Pain

Brief summary

Colposcopy is essential for the diagnosis and prevention of cervical cancer. However, receiving screening results and being informed of the need to undergo a colposcopic examination are significant sources of anxiety for patients. This randomized controlled study aims to evaluate the impact of an intervention by a clinical nurse prior to a first colposcopy on patients' situational anxiety. Secondary objectives include patient satisfaction, perceived pain during the examination, and the exploration of sociodemographic factors related to anxiety.

Interventions

OTHERPre-colposcopy counseling by a clinical nurse

In the intervention group, the clinical nurse conducted a structured pre-colposcopy counseling session covering the following topics: verification of the patient's understanding of the reason for the colposcopy referral, explanation of the cervical cytology result, the procedure of the colposcopy, expectations regarding pain, the role of HPV in the development of precancerous and cancerous cervical lesions, counseling on HPV vaccination, and smoking cessation.

OTHERTreatment as usual: regular call to schedule the appointment without pre-procedure conseilling

In the control group, patients simply received a phone call to notify them of their appointment and, upon arrival, were given an information sheet about colposcopy. No pre-colposcopy discussion was conducted.

Sponsors

Université de Sherbrooke
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 65 Years
Healthy volunteers
No

Inclusion criteria

* People with a cervix * 21-65 years old * Speaking French * Abnormal pap smears warranting a colposcopy

Exclusion criteria

* Refusal to participate * Inability to provide consent. * Having previously undergone a colposcopy. * Being pregnant * Having a reason for consultation other than an abnormal cytology result (such as VIN, VAIN, suspected cancer, vulvar dermatological issues, etc.).

Design outcomes

Primary

MeasureTime frameDescription
Pre-procedure situational anxietyOn the day of the colposcopy procedureThe pre-procedure situational anxiety is measured on the day of the colposcopy using the State Trait Anxiety Inventory (STAI). The STAI is a validated 20 item self report assessment device which includes separate measures of state and trait anxiety. The minimum value is 20 and the maximum value is 80. Higher scores indicate greater anxiety.

Secondary

MeasureTime frameDescription
Pain level perceived during the colposcopy procedure measured by a visual analog scale (VAS scale)Immediately after the colposcopy procedureWe measured the pain level perceived during the colposcopy procedure using a visual analog scale ranging from 0 to 10. Highest scores indicated higher level of pain perceived during the procedure.
Patient's satisfaction levelImmediately after the colposcopy procedurePatient satisfaction levels were assessed using the standardized Patient's Experience and Attitude Colposcopy Eindhoven Questionnaire (PEACE-q). It is a validated 8-item user-friendly self-rating tool with with questions on: level of being informed, preoccupation, level of stress and level of ease created during consultation. The 8 items are rated on a 4-point Likert scale (final scores ranging from 8 to 32). Higher scores indicate a more positive experience of the colposcopy procedure.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026